ARTICLE | Politics & Policy

ICER publishes final framework for Orphan Drug assessment

November 14, 2017 10:10 PM UTC

The Institute for Clinical and Economic Review published its final value framework to be applied in the assessment of Orphan Drugs for serious ultra-rare conditions. The modifications to the framework are in line with the proposed changes the institute outlined in July (see BioCentury Extra, July 26)...